The incidence and outcome of respiratory distress syndrome in preterm babies in relation to administration of antenatal corticosteroids
DOI:
https://doi.org/10.32677/IJCH.2018.v05.i04.009Keywords:
Antenatal corticosteroid, Preterm, Respiratory distress syndrome, SurfactantAbstract
Background: Premature infants have a higher incidence of respiratory distress syndrome (RDS), which is one of the main causes of early neonatal mortality. Objectives: The objective is to study the incidence and outcome of RDS in preterm babies <34 weeks of gestation born to mothers who had received antenatal corticosteroids (ACS). Methodology: A prospective observational study was conducted among preterm babies from January 2015 to December 2015 in a tertiary care hospital of South India. Details of the mothers with a period of gestation 34 weeks or less who had received ACS were recorded. Results: The study population included 749 preterm babies (<34 weeks) delivered in our hospital. Among them, 698 (93.2%) mothers received two doses of ACS and 51 (6.8%) received only a single dose of ACS. Neonates whose mothers received two doses of ACS had a significantly lower incidence of RDS (27.6% vs. 100%, p<0.001), lower rate of mechanical ventilation (45% vs. 72.5%, p<0.001), and higher survival rate (87% vs. 68.6%, p=0.001) than neonates whose mothers received a single dose of ACS. The occurrence of RDS is highest in 26
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Shermin Nasreen Abdul Jaleel, Bindu Sarojum, Bindusha Sasidharan, Priya Gopala Krishnan

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.